Atlantic Healthcare's drug fails late-stage test; Translate Bio breaks out early CF data
→ Cambridge, UK-based Atlantic Healthcare disclosed that the late-stage program for its experimental drug, alicaforsen enema, has failed in patients with pouchitis, a progressive disease …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
